AzTrials
AzTrials

Simple Renal CystNCT05134077

Influence of Simple Renal Cysts on Renal Function

A study testing CT scan with contrast and Nephroscintigraphy in people with Simple Renal Cyst and Renal Function Disorder, run by Moscow State University of Medicine and Dentistry.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a prospective, cohort, randomized clinical trial examining the effect of simple renal cysts on renal function. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Simple Renal Cyst, Renal Function Disorder
What is being tested?
CT scan with contrast and Nephroscintigraphy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
No sites listed yet
Study dates
16 Feb 2022to 1 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients with simple kidney cyst Bosniak 1-2
  • Normal blood creatinine values

Who cannot join

  • Impossibility of performing CT with intravenous contrast enhancement.
  • Bosniak 3-4
  • CKD
  • Bilateral cysts
  • Multiple renal cysts
  • Sinus cysts
Show all 29Show fewer
  • Cysts with a max size less than 2 cm.
  • Single kidney
  • Chronic kidney disease and conditions associated with the potential decrease of kidney function
  • Glomerulonephritis
  • Chronic pyelonephritis
  • Amyloidosis
  • Diabetes
  • Autoimmune diseases
  • Urolithiasis
  • Kidney and upper urinary tract surgery
  • Anomalies of the kidneys and upper urinary tract with impaired outflow
  • Calcification of the renal arteries
  • Renal artery stenosis
  • Hypertensive nephropathy
  • Severe concomitant diseases requiring
  • Chemotherapy
  • Long-term (more than 10 days) antibiotic therapy in the last month
  • Long-term (more than 7 days) use of NSAIDs in the last month
  • Diagnostic and therapeutic manipulations accompanied by the introduction of X-ray contrast agents
  • Secondarily shriveled or non-functioning kidney
  • Kidney hypoplasia
  • Accessory kidney
  • a decrease in GFR below normal values for a kidney without a cyst (as determined by nephroscintigraphy)

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Influence of Simple Renal Cysts on Renal Function: Cohort Clinical Trial.

This is a prospective, cohort, randomized clinical trial examining the effect of simple renal cysts on renal function.

Read the detailed description

This study is planned to include patients from S.I. Spasokukotskiy Citi Clinical Hospital with simple renal accidentally discovered cyst.

The aim of the study is to evaluate the impact of simple renal cysts on renal function and explore the correlation between cyst's size, parenchymal atrophy, and renal function.

After receiving the results, the analysis of the data obtained is carried out.

  1. The symmetry of the function of both kidneys is analyzed
  2. The relationship between the presence of a simple kidney cyst and a decrease in its function in comparison with a healthy kidney is analyzed.
  3. The relationship between the maximum size of a kidney cyst and a decrease in its function in comparison with a healthy kidney is analyzed.
  4. The relationship between the volume of the atrophied kidney parenchyma and a decrease in its function as compared with a healthy kidney is analyzed.
  5. Correspondence of GFR indices obtained by scintigraphy and by calculation using the Schwartz formula
Being tested
CT scan with contrast, Nephroscintigraphy
Keywords
Simple Renal Cyst, Renal Function

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CT scan with contrastProcedure or surgery

    CT scan with contrast is necessary to determine the position of renal cysts, their location, and size (determine volume of atrophic parenchyma will be calculated).

  • NephroscintigraphyRadiation

    Nephroscintigraphy is necessary to determine the renal function

Study groups in NCT05134077
Study groupRoleWhat they receive
kidneys with simple cystsExperimentalPatients involve from Citi Clinical Hospital with simple renal accidentally discovered cyst.
Receives: Procedure: CT scan with contrast; Radiation: Nephroscintigraphy
contralateral kidneys without cystActive comparatorРatients involve from Citi Clinical Hospital with simple renal accidentally discovered cyst.
Receives: Procedure: CT scan with contrast; Radiation: Nephroscintigraphy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Renal function

    Glomerular filtration rate (GFR, ml/min/1.73 m2) is a test used to check how well the kidneys are working. Specifically, it estimates how much blood passes through the glomeruli each minute. A GFR of 60 or higher is in the normal range. A GFR below 60 may mean kidney disease. A GFR of 15 or lower may mean kidney failure.

    The measurement of the glomerular filtration rate will be measured according to the results of the blood test and the results of nephroscintigraphy

    Measured: 1 month

Secondary outcomes (1)
  1. Ratio of cyst size and volume of atrophic renal parenchyma

    Computed tomography with contrast will be used to determine the position of renal cysts, their location, size and volume of atrophic parenchyma (cm2) are calculated

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2021
  2. Study start16 Feb 2022 (estimated)
  3. Primary completion8 Mar 2022 (estimated)
  4. Study completion1 May 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
We present a cohort study of patients with renal cysts (the first group - kidneys with cysts, the second group - kidneys without cysts in the studied patients). All patients will undergo contrast-enhanced CT of the urinary system (volume of atrophic parenchyma will be calculated), as well as nephroscintigraphy.
Masking
None (open label)
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05134077
Sponsor's protocol ID
SRC
Status last verified
Nov 2021
First submitted
19 Oct 2021
Last updated
24 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing CT scan with contrast and Nephroscintigraphy in people with Simple Renal Cyst and Renal Function Disorder, run by Moscow State University of Medicine and Dentistry.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 29 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Vigen Malkhasyan (+7(909) 644-16-88, vigenmalkhasyan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Renal function (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in